Agilus Diagnostics, earlier known as SRL, has withdrawn its initial public offering plan in the last week on Feb 12. The Agilus Diagnostics IPO consisted of only an OFS of 1,42,33,964 equity shares by the existing shareholders, with no fresh issue component. International Finance Corp, NYLIM Jacob Ballas India Fund III LLC, and Resurgence PE Investments were the selling shareholders in the OFS.
Read more at MoneycontrolAd
Ad